INCYTE CORPORATION revenue for the last year amounted to 62.77 B MXN, the most of which — 62.77 B MXN — came from its highest performing source at the moment, Proprietary Therapeutics, the year earlier bringing 66.21 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought INCYTE CORPORATION 59.45 B MXN, and the year before that — 62.41 B MXN.